ABSTRACT Background: A low or high body mass index (BMI) has been associated with increased mortality risk in older subjects without taking fat mass index (FMI) and fat-free mass index (FFMI) into account. This information is essential because FMI is modulated through different healthcare strategies than is FFMI. Objective: We aimed to determine the relation between body composition and mortality in older subjects. Design: We included all adults $65 y old who were living in Switzerland and had a body-composition measurement by bioelectrical impedance analysis at the Geneva University Hospitals between 1990 and 2011. FMI and FFMI were divided into sex-specific quartiles. Quartile 1 (i.e., the reference category) corresponded to the lowest FMI or FFMI quartile. Mortality data were retrieved from the hospital database, the Geneva death register, and the Swiss National Cohort until December 2012. Comorbidities were assessed by using the Cumulative Illness Rating Scale. Results: Of 3181 subjects included, 766 women and 1007 men died at a mean age of 82.8 and 78.5 y, respectively. Sex-specific Cox regression models, which were used to adjust for age, BMI, smoking, ambulatory or hospitalized state, and calendar time, showed that body composition did not predict mortality in women irrespective of whether comorbidities were taken into account. In men, risk of mortality was lower with FFMI in quartiles 3 and 4 [HR: 0.78 (95% CI: 0.62, 0.98) and 0.64 (95% CI: 0.49, 0.85), respectively] but was not affected by FMI. When comorbidities were adjusted for, FFMI in quartile 4 (.19.5 kg/m 2 ) still predicted a lower risk of mortality (HR: 0.72; 95% CI: 0.54, 0.96). Conclusions: Low FFMI is a stronger predictor of mortality than is BMI in older men but not older women. FMI had no impact on mortality. These results suggest potential benefits of preventive interventions with the aim of maintaining muscle mass in older men. This trial was registered at clinicaltrials.gov as NCT01472679. Am J Clin Nutr 2015;101:760-7.
INTRODUCTION

BMI (in kg/m
2 ) is often used to evaluate body composition (BC). 5 BMI has been linked to mortality in older subjects through a U-shaped or J-shaped relation (1) (2) (3) (4) (5) (6) (7) (8) (9) , which means that low or high BMI increases risk of mortality. However, BMI can only estimate BC and may not reflect fat mass (FM) or fat-free mass (FFM), which is the body mass devoid of any fat and includes skeletal muscle mass. This estimation has been illustrated in healthy adults in whom high BMI reflected high FFM and FM in women but only high FM in men (10) . Furthermore, consideration of BMI may underestimate FFM depletion as shown in patients with chronic hypercapnic respiratory failure (11) , with cancer (12) , or undergoing hemodialysis (13) .
The discrepancies between BMI and BC raise the question of whether FFM and FM are more important predictors of mortality than is BMI in older subjects. This issue is important because advancing age is associated with a decline of skeletal muscle mass and function (14) , which is referred to as sarcopenia, and an increase or decrease of FM (15, 16) . The identification of the compartment of BC associated with mortality would allow better targeting of health care strategies. For instance, a loss of FFM can be prevented by resistance exercises (17) , adequate calorie intake and protein supplementation (18) or hormonal therapies (19) , whereas FM can be reduced by a hypocaloric diet and endurance exercises (17) .
Large cohort studies that included elderly subjects showed either no association between BC and mortality (20, 21) or increased risk of mortality with low FFM (22) (23) (24) . These inconsistent results may have been related to different study populations and methods. In clinical routine, whole BC is generally measured by using bedside methods such as skinfold thicknesses and circumferences or bioelectrical impedance analysis (BIA). BIA offers a better interobserver reliability than do bedside methods (25) . In the current study, we examined the relation between BMI, BC measured by BIA, and all-cause mortality in community-dwelling and hospitalized subjects aged $65 y who were living in Switzerland and evaluated the impact of comorbidities on this relation.
METHODS
Subjects and design
The current trial was a historical cohort study of prospectively collected BC measurements performed at the Geneva University Hospitals (HUG) between January 1990 and December 2011.
We included all subjects aged $65 y who were hospitalized or not and underwent one BC measurement with a 50-kHz BIA at the HUG either in a research setting or clinical routine. Details about subjects included are provided in Supplemental Methods 1. Exclusion criteria were as follows: residency outside of Switzerland because mortality data would be difficult to retrieve; death #1 mo of BIA measurement because the relation between BC and mortality could change in the terminal phase of life; missing height or weight; negative FM, which was likely due to fluid and electrolyte disturbances unknown by the nutrition team and invalidated BIA measurements (Supplemental Table 1 ); and duplicates. The Ethical Committee of the HUG accepted the protocol, which was registered at clinicaltrials.gov as NCT01472679, and waived the need to obtain informed consent.
BC measurements
Data on BMI (weight divided by the square of height) and BIA measurements were retrieved from the following 2 sources: 1) the clinical computer database of the HUG, which has been available since January 2000 for clinical consultations, and 2) the database of the nutrition unit, which includes BIA measurements performed for clinical purpose between January 1990 and December 1999 and, for research projects, between January 1990 and December 2011.
The retrieved data consisted of the 50-kHz resistance, reactance, impedance, phase angle, date of BC measurement, and sex as well as height, weight, and age on the day of BIA measurement. Methods to measure weight, height, and BIA variables were standardized as previously described (16) . For BIA measurements, each subject laid on his or her back with arms and legs abducted from the trunk by w308 and 458, respectively. Adhesive electrodes were placed on the dorsal surface of the right hand, wrist, foot, and ankle as described elsewhere (26) after cleaning the skin with 70% alcohol. A generator applied an alternating current of 50 kHz and 0.8 mA to these electrodes. The measured resistance and reactance allowed the calculation of FFM by using the Geneva formula (27) , which was developed in the Geneva population and validated in subjects aged $65 y against dual-energy X-ray absorptiometry (28) . FM was obtained by subtracting FFM from body weight (27) . FFM and FM were converted to fat-free mass index (FFMI) and fat mass index (FMI) by dividing them by the square of height (m 2 ). For the analysis, we considered only the last BIA measurement of each subject, which is, by definition, the closest to death and, thus, may better predict mortality than a more ancient one.
Because the measurements included were performed over 21 y, several bioelectrical impedance analyzers had been used to measure BC [RJL-101 (RJL Systems Inc.), Xitron 4000B (Xitron Technologies), Eugedia (Eugédia-Spengler), Bio-Z (Spengler), and Nutriguard (Data Input GmbH)]. All devices were calibrated with a calibration jig (CJ 4000; Xitron Technologies) that measured impedance and phase angle. These variables are linked to resistance and reactance through a mathematical relation (26) . The limit of tolerance at 50 kHz was set at 628 for the phase angle and 65 U for the impedance. In vivo, the method agreement between devices was 0.03 kg for FFM (95% CI: 21.7, 2.1 kg), and the interobserver agreement was 0.02 kg for FFM (95% CI: 21.3, 1.3 kg) (16) (Supplemental Methods 2).
Reporting of diseases and lifestyle modes
We retrieved data on diseases and smoking at the time of BC measurements on the basis of discharge reports in case the patient was hospitalized or ambulatory consultation reports. These reports allowed for the calculation of the Cumulative Illness Rating Scale (CIRS) (29) (Supplemental Methods 3). The CIRS is a strong predictor of mortality and functional limitation (30, 31) , and it rates 14 organs and systems from 0 (no disease) to 4 (severe disease requiring immediate treatment or hospitalization) points with a maximum score of 56 points. In our study, 2 raters performed the retrospective scoring of the CIRS. The interrater Spearman's correlation coefficient on the basis of the CIRS of 20 randomly assigned subjects was 0.92.
All-cause and cause-specific mortality
Dates of death were retrieved by using the following 3 different official sources: the clinical computer database of the HUG, the Geneva population register of deaths (32) , and the Swiss National Cohort (33) . The Swiss National Cohort is a national data platform that anonymously links all-cause and cause-specific mortality to national censuses by using the International Statistical Classification of Diseases and Related Health Problems, 10th revision, for coding. Details on these mortality sources are available online (Supplemental Methods 4). The flowchart in Supplemental Figure 1 summarizes the merging of BC, CIRS, and mortality data.
Statistics
Characteristics of subjects at last follow-up are presented as means (6SDs) for continuous variables and absolute and relative numbers of subjects for ordinal categories. The normality of the distribution of continuous data was verified by using Shapiro-Wilks tests. Unpaired t tests compared continuous variables, and Mann-Whitney U tests compared ordinal categories between women and men and community-dwelling and hospitalized subjects. BC was correlated with BMI and the CIRS by using Pearson's correlations. The significance level was set at P , 0.05 but was corrected to P , 0.04 for multiple testing by using the Benjamini-Hochberg method (34) .
We used Cox regression models with the observation time as the underlying time scale and adjusted for age by using 3 categories (65-74, 75-84, and $85 y). Because the relation between BMI and mortality is not linear, BMI was categorized as Because BC is different in men and women, whole analyses were done by sex, including the determination of FMI and FFMI quartiles. The CIRS was not normally distributed, which led to a categorization into quartiles. We described cutoffs of each quartile of FMI, FFMI, and CIRS and calculated mortality trends across quartiles of BC. Smoking was also considered because it is a strong predictor of mortality in older subjects (35) . Sex-specific univariate Cox regressions tested the relation between mortality and the aforementioned ordinal categories. Kaplan-Meier curves were performed to illustrate mortality according to BC and the CIRS.
Sex-specific multiple Cox regression models evaluated the prediction of mortality through age, BMI, smoking status, ambulatory or hospitalized status, calendar time (model 1), and, in addition, CIRS categories (model 2). Models 3 and 4 corresponded to models 1 and 2 respectively, but with the inclusion of FFMI and FMI quartiles. In the 4 models, we tested the collinearity between predictor variables by calculating their variance inflation factor. All values were ,10, indicating the absence of significant collinearity. For each predictor variable, we verified the proportional hazards assumptions graphically by plotting ln [2ln(survival probability)] compared with ln(time). We calculated HRs and their 95% CIs as well as the adjusted R 2 values and their 95% CIs, which corresponded to the variance of mortality explained by the model. To compare different models, we used the R 2 and 95% CI calculated in the same number of subjects in each model. Interactions were calculated between FFMI and FMI quartiles in models 3 and 4. Cox regression models were replicated while excluding patients with severe neurological disease, which could influence BC.
Statistical analyses were performed with Stata version 13.1 software (StataCorp LP). We did not perform a power analysis because FFMI was known to predict mortality in smaller study populations (23) .
RESULTS
We included 3181 subjects, whose characteristics at the last BIA measurement are presented in Table 1 . Women were older, healthier, and had lower FFMI but higher FMI and FM (%) than did men. Compared with hospitalized subjects, communitydwelling men and women were younger, healthier, and had Table 2 ). FFMI and FMI were positively correlated with the BMI in both sexes (Supplemental Figure 2 ) but negatively correlated with the CIRS in men (Supplemental Figure 3) . Cutoffs of FFMI, FMI, and CIRS quartiles used in subsequent Cox regressions are shown in (12) . Of these subjects, 1773 people (56%) died. Women died at an older age than did men ( Table 1 ). The median (IQR) follow-up between the BIA measurement and death for the 1773 people who died was 2.0 y (4.8 y) [3.0 y (6.3 y) for 766 women and 1.4 y (3.8 y) for 1007 men]. The primary causes of mortality, which were retrieved in 1556 subjects (88%), were mostly from cancer (32%), cardiovascular diseases (28%), and respiratory diseases (13%), which corresponded to the main causes of death in Switzerland in subjects aged $65 y (36) .
Mortality trends decreased with higher FFMI in men and women and higher FMI in men (Supplemental Table 3 ). Univariate Cox regressions (Supplemental Table 4 ) highlighted that mortality risk increased with higher age categories. BMI ,18.5, lower FFMI and FMI quartiles, higher CIRS scores, past or present smoking, and hospitalization. Kaplan-Meier curves showed that the mortality was decreased with BMI between 25 and 34.9 (Supplemental Figure 4) and a low CIRS (Supplemental Figure 5 ) in both sexes. With regard to BC, Figure 1 shows a protective effect of higher FFMI quartiles in men and women when unadjusted for other variables. Multiple Cox regressions in women showed that a high BMI was associated with better survival only when the CIRS was considered ( Table 3 , models 2 and 4). However, FFMI and FMI did not predict mortality in any model. In men, BMI .25 was associated with better survival irrespective of whether the CIRS was considered ( Table 4 , models 1 and 2). The addition of BC to these models reduced the impact of BMI on mortality and showed that risk of mortality progressively decreased with higher FFMI but was not influenced by FMI (model 3). When the CIRS was adjusted for (model 4), FFMI in quartile 4 remained a significant protector against mortality in men. There were no interactions between FMI and FFMI in either sex in models 3 and 4.
The comparison of the 4 multiple Cox regression models required the same number of subjects in each model and, thus, was restricted to the available CIRS (1176 women and 1480 men) in models 1 and 3 (Supplemental Table 5 ). The R 2 for the 4 models ranged from 0.14 to 0.20 for women and from 0.13 to 0.20 for men. Models with the CIRS yielded the highest R 2 values (Supplemental Table 6 ).
The exclusion of patients with a neurologic CIRS .3 (455 women and 410 men) showed that FFMI in quartile 4 was still associated with decreased mortality risk in models 3 (HR: 0.66; 95% CI; 0.48, 0.87; P = 0.004) and 4 (HR: 0.73; 95% CI; 0.54, 0.98; P = 0.039) in men.
DISCUSSION
This study showed that, in the absence of adjustment for comorbidities, BMI $25 had no impact on mortality in older women but was associated with lower risk of mortality in older men. The addition of BC to Cox regression models including BMI highlighted that FFMI and FMI did not predict mortality in women. In men, FFMI in quartile 4 (.19.5 kg/m 2 ) was associated with lower risk of mortality even after adjustment for comorbidities. Women and men considered in this study died at the age of 82.8 6 8.5 and 78.5 6 7.6 y, respectively. Life expectancy in Switzerland was 83 y in women and 77 y in men in the year 2000, and currently, it has increased to 85 y in women and 81 y in men (37) . Thus, the age at death in our population reflected the age at death of the Swiss population. This life expectancy is only slightly higher than that in the United States, the United Kingdom, Chile, and Denmark, where cohort studies that evaluated the impact of BC on mortality were performed.
Cohort studies reported diverging effects of FFMI on mortality (20) (21) (22) (23) (24) . In the United States, Kuk et al. (23) measured BC by using BIA, skinfold thickness, and waist-to-hip ratio in 2316 community-dwelling subjects aged .65 y. Over 8.7 y, there were 911 deaths. The authors created 5 sex-specific BC cutoffs that corresponded to standard BMI categories. Cox regression models were adjusted for physical activity, smoking status, social status, dietary fat content, alcohol consumption, and medical history evaluated by subject-administered questionnaires. Risk of mortality increased in the first compared with second quartile of FFMI (#15.8 compared with 15.9-18.7 kg/m 2 ) in men aged 65-75 y. The waist-to-hip ratio, which is a marker of abdominal fat, but not the FM percentage, was inversely associated with mortality in men. BC had no impact on mortality in women. In our study, risk of mortality progressively decreased with higher FFMI in men and was lower in the fourth than in the first quartile of FFMI (FFMI .19.5 compared with ,16.2 kg/m 2 ) even after adjustment for comorbidities. These slight differences may have been related to different adjustments in the Cox regression models. Kuk et al. (23) did not report FMI or introduced FFMI and FMI simultaneously in one Cox regression model. They adjusted their models for several variables, which were not available in our study, but not for comorbidities, which is one of the most powerful predictors of mortality. 
IMPACT OF BODY COMPOSITION ON MORTALITY
Another study was performed on 4107 male outpatients aged 60-79 y who were living in Great Britain (20) . The patients underwent measurements of BMI and FFM by BIA. During the mean follow-up of 6 y, 713 deaths occurred. Mortality was lowest in men with BMI between 25 and 29.9 after adjustment for age, physical activity, smoking, alcohol consumption, and social class but was not related to FFMI or FMI. Moreover, the Cox regression models did not include FFMI and FMI simultaneously, were not adjusted for the same variables as in our study, and did not evaluate the impact of comorbidities.
In Chile, Bunout et al. (21) included 1513 community-dwelling subjects with a mean age of 74 y, excluding those with cancer and cardiac or renal failure. They measured BC by dual-energy X-ray absorptiometry. During a median follow-up of 4.5 y, 221 subjects died. Mortality was not associated with FFM divided by height when stratified by sex. Unfortunately, the authors did not report the effect of FMI or BMI and provided no indication as to whether a sex-specific HR was calculated.
Han et al. (22) followed 876 community-dwelling Korean subjects aged .65 y who underwent BIA measurements during 3.5 y. Death occurred in 55 subjects. BC was separated into tertiles. In Cox regression analyses adjusted for age, sex, smoking, physical exercise, laboratory variables, and some medical conditions, the HR progressively decreased with higher FFMI tertiles compared with the FFMI tertile ,14.6 kg/m 2 . FM had no impact on mortality, but the authors did not perform sex-specific Cox regressions.
Finally, an impressive cohort study included more than 50,000 Danish men and women aged 50-64 y, who, thus, were slightly younger than those in the aforementioned studies (24) . The authors measured BC by BIA with a population-specific equation and followed them for a median length of 5.8 y. FFMI ,19.7 kg/m 2 in men and ,16.6 kg/m 2 in women was associated with increased risk of mortality when adjusted for FMI and smoking in both sexes.
In summary, these cohort studies generally described increased risk of mortality with low FFMI in men but not women. The differences may have been related to different methods for measuring BC and, when BIAwas used, depended on the type of device or equation used to derive FFM. The accuracy of the equation depends on the reference method used for its development and characteristics of the study population in whom the equation has been validated, such as, e.g., ethnicity, environment, and age.
The strength of this current study was that BIA-derived BC was calculated by using a population-specific BIA formula (27) validated in older subjects (28) . Cox regression models were adjusted for the CIRS, which takes into account the severity of many comorbidities. However, our study had several limitations. The CIRS was calculated retrospectively on the basis of discharge reports and ambulatory consultations. However, the CIRS was validated as a retrospective tool and may be preferable to questionnaires, which are subjective (29) . The impact of alcohol consumption was not evaluated directly but included in the CIRS, the systems "liver and biliary diseases," and "psychiatric and behavioral diseases." We have no information on physical activity at the time of BIA measurements in contrast with some of the aforementioned studies. Nevertheless, physical activity may have changed after the BC measurement, and it would probably be more important to take into account physical activity performed in the timeframe between BC measurements and death, which to our knowledge, no study has done. We included obese subjects as in the aforementioned studies (20, 22, 23) , although the accuracy of the BIA is questionable in these subjects (38, 39) . Finally, we used several types of BIA devices. However, they were all calibrated against the same calibration jig, which should have limited differences in BC related to devices.
In conclusion, our study highlights that BC did not predict mortality in older women irrespective of whether comorbidities were considered. In older men, FFMI seems to be the main factor of BC predicting mortality even when adjusted for comorbidities. These results suggest potential benefits of preventive interventions aimed at maintaining muscle mass in older men. Future studies should evaluate the impact of such strategies.
